The global infectious disease rapid diagnostics devices market is experiencing robust expansion as timely disease detection becomes a global healthcare priority. Valued at US$ 9.7 billion in 2024, the market is projected to grow at a CAGR of 6.9% from 2025 to 2035, exceeding US$ 20.2 billion by 2035. The accelerating burden of infectious diseases and the need for immediate and decentralized testing are driving worldwide adoption of rapid diagnostic technologies.

Access key findings and insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86762

Growing Need for Early Detection and Pandemic Preparedness

Frequent outbreaks of emerging and re-emerging pathogens-including COVID-19, influenza variants, HIV, tuberculosis, and viral hepatitis-have reinforced the critical role of real-time diagnostics. Rapid tests enable early identification, isolation, and treatment decisions, helping reduce disease transmission and mortality.

Governments, global health organizations, and private sectors are heavily investing in diagnostic innovation and pandemic preparedness infrastructure, creating strong, sustained market opportunities.

Shift Toward Point-of-Care and Home-Based Testing

Technological advancements have significantly improved the accuracy, portability, and ease of use of rapid diagnostic devices. The growing adoption of point-of-care (POC) and at-home test kits allows healthcare providers and consumers to make quick decisions without waiting for centralized lab results.

Key advances include:

Microfluidic and lab-on-chip platforms
Molecular point-of-care PCR systems
AI-enabled test interpretation
Smartphone-integrated diagnostics
Multiplex testing for simultaneous pathogen detection

These innovations are reducing testing complexity while broadening access in low-resource and rural settings.

Explore our report to uncover in-depth insights - https://www.transparencymarketresearch.com/infectious-disease-rapid-diagnostics-devices-market.html

Competitive Landscape

The infectious disease rapid diagnostics devices market is highly competitive and innovation-driven, with leading players focusing on molecular POC systems, data connectivity, and expanded test menus.

Prominent companies include:
F. Hoffmann-La Roche AG
Abbott
Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific Inc.
Becton, Dickinson and Company (BD)
bioMérieux SA
Diasorin S.p.A.
Hologic, Inc.
QuidelOrtho Corporation
Siemens Healthineers AG
Seegene Inc.
QIAGEN
Danaher Corporation
Trinity Biotech
Grifols

These companies continue to expand through R&D investment, strategic collaborations, and enhanced manufacturing capacities.

Regional Market Outlook

North America maintains a leading share due to advanced healthcare infrastructure and high R&D investment.

Europe shows strong demand through national screening programs and public health initiatives.

Asia-Pacific is the fastest-growing region, driven by rapid urbanization, infectious disease prevalence, and expanding POC accessibility in India, China, and Southeast Asia.

Africa and Latin America continue to receive major investments from global health organizations for infectious disease control.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453